ScholarIQanswers from OpenAlex

In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma

PaperCitations, authors & open-access status

In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma have?

ScholarIQcitation count

In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma has 84 citations in the OpenAlex counts ScholarIQ stores.

When was In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma published?

ScholarIQyear

In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma has 2012 year in the ScholarIQ index.

What is the open-access status of In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma?

ScholarIQoa status

In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma has gold oa status in the ScholarIQ index.

What is the DOI of In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma?

ScholarIQdoi

The DOI for In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma is on the source record.

What is the PMID of In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma?

ScholarIQpmid

The PMID for In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma is on the source record.

What is the OpenAlex record for In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma?

ScholarIQopenalex

The OpenAlex for In vitro and in vivoanti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial